Approvals/TGA/MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet bottle

Approved

STANDARD

MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet bottle

AbbVie Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 2a71acc2ce7ecafd
Product Name: MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet bottle
Artg Id: 325401
Artg Name: MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet bottle
Sponsor: AbbVie Pty Ltd
Company Detail Path: /organization/abbvie-pty-ltd
Artg Date: 2020-01-16
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/e0186bd6e96d38804e509f377c5fb411.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/9a040e456036049ca312b1c60c01f043.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

2a71acc2ce7ecafd

Type

Standard